Quantcast
Last updated on April 16, 2014 at 17:34 EDT

Latest ovarian cancers Stories

2013-10-15 08:33:34

Also Releases Results from National Harris Survey Revealing Widespread Confusion about BRCA Testing MADISON, N.J., Oct. 15, 2013 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced the availability of BRCAvantage(TM), a suite of four new lab-developed genetic tests (LDT) that identify mutations in BRCA1 and BRCA2 genes, which are associated with increased risk of inherited breast and ovarian cancers. Serving...

2011-09-23 07:19:13

(Ivanhoe Newswire) -- Ovarian tumors can be deadly - especially if gone undetected like so many are. A new study, published in the September 20 issue of PLoS Biology, may shed light on how these deadly tumors develop and spread. Stanford researchers, including Patrick O. Brown, senior author of the study and Howard Hughes Medical Institute investigator, were specifically looking for evidence that an ovarian tumor had rearranged its DNA so that two distinct genes were now fused together....

2011-09-21 12:12:25

Researchers studying ovarian cancer have discovered that, in a substantial fraction of ovarian tumors, a gene closely related to the estrogen receptor is broken and fused to an adjacent gene by a chromosome rearrangement; a finding that could shed light on how these deadly tumors develop and spread. Identifying a gene fusion in ovarian cancer may provide scientists with a new opportunity to specifically identify ovarian cancers early in their development and perhaps to develop new treatments....

2011-09-01 15:32:02

It is widely known that mutations in the breast cancer susceptibility 1 (BRCA1) gene significantly increase the chance of developing breast and ovarian cancers, but the mechanisms at play are not fully understood. Now, researchers at Virginia Commonwealth University Massey Cancer Center have shown that certain BRCA1 mutations result in excessive, uncontrolled DNA repair, which challenges the prior assumption that mutations in BRCA1 only contribute to breast cancer through a reduction in...

2010-08-17 17:00:06

Inhibiting a cell division-regulating protein can improve response to taxane chemotherapy For the first time, Salt Inducible Kinase 2 (SIK2) has been found to play a critical role in cell division and to regulate the response of some ovarian cancers to chemotherapy. Findings were reported by researchers from The University of Texas MD Anderson Cancer Center in the August issue of Cancer Cell. The study adds to growing evidence that combination therapies targeting different phases of the cell...

2007-09-10 06:00:08

Myriad Genetics, Inc. (NASDAQ: MYGN) announced today that it has launched a comprehensive public awareness advertising campaign -- known as the BRACAnalysis(R) Awareness Campaign -- designed to reach women with a family history of breast and/or ovarian cancer, and the healthcare providers that treat them. It is estimated that there are more than a million people in the United States with inherited genetic mutations predisposing them to an increased risk of cancer. It is estimated that fewer...